{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:54:32Z","timestamp":1780084472040,"version":"3.54.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["Award Number 7772608, IND #13691"],"award-info":[{"award-number":["Award Number 7772608, IND #13691"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["Award Number 7772608, IND #13691"],"award-info":[{"award-number":["Award Number 7772608, IND #13691"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-39826-4","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:17:14Z","timestamp":1771237034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Probiotic intervention not beneficial to prevent antibiotic-associated diarrhea in absence of antibiotic-induced microbiome disruption"],"prefix":"10.1038","volume":"16","author":[{"given":"Daniel","family":"Merenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Grant-Beurmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ellen","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneesha","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisha","family":"Herbin-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessy","family":"Sparenborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"39826_CR1","unstructured":"Centers for Disease Control and Prevention. Outpatient antibiotic prescribing in the United States. CDC.gov. https:\/\/www.cdc.gov\/antibiotic-use\/hcp\/data-research\/antibiotic-prescribing.html"},{"key":"39826_CR2","doi-asserted-by":"crossref","unstructured":"Suda, K. J., Hicks, L. A., Roberts, R. M., Hunkler, R. J. & Taylor, T. H. Danziger L.H. Antibiotic expenditures by medication, class, and healthcare setting in the united States, 2010\u20132015. PLoS One 14, e0219681 .","DOI":"10.1093\/ofid\/ofv133.24"},{"key":"39826_CR3","doi-asserted-by":"crossref","unstructured":"Shapiro, D. J., Hersh, A. L., Pavia, A. T. & Shah, S. S. Antibiotic prescribing for adults in ambulatory care in the USA, 2007\u201309. J Antimicrob. Chemother 69, 234\u2013240 .","DOI":"10.1093\/jac\/dkt301"},{"key":"39826_CR4","unstructured":"Finkelstein, Y., Stein, R. J. & Weller, D. Comparing narrow- and broad-spectrum antibiotics for common infections in children. PCORI Evid. Updates https:\/\/www.pcori.org\/evidence-updates\/comparing-narrow-broad-spectrum-antibiotics-for-common-infections-in-children"},{"key":"39826_CR5","unstructured":"Guo, Q., Goldenberg, J. Z., Humphrey, C. & El Dib, R. Johnston B.C. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst. Rev 4, CD004827 ."},{"key":"39826_CR6","doi-asserted-by":"crossref","unstructured":"Fijan, S. et al. Health professionals\u2019 knowledge of probiotics: an international survey. Int J. Environ. Res. Public. Health 16, 3128 .","DOI":"10.3390\/ijerph16173128"},{"key":"39826_CR7","doi-asserted-by":"crossref","unstructured":"Turck, D. et al. Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population. J Pediatr. Gastroenterol. Nutr 37, 22\u201326 .","DOI":"10.1002\/j.1536-4801.2003.tb08099.x"},{"key":"39826_CR8","doi-asserted-by":"crossref","unstructured":"Mitchell, D. K., Van, R., Mason, E. H., Norris, D. M. & Pickering, L. K. Prospective study of toxigenic Clostridium difficile in children given amoxicillin\/clavulanate for otitis media. Pediatr Infect. Dis. J 15, 514\u2013519 .","DOI":"10.1097\/00006454-199606000-00008"},{"key":"39826_CR9","doi-asserted-by":"crossref","unstructured":"McCarty, J. M., Phillips, A. & Wiisanen, R. Comparative safety and efficacy of clarithromycin and amoxicillin\/clavulanate in the treatment of acute otitis media in children. Pediatr Infect. Dis. J 12, S122\u2013127 .","DOI":"10.1097\/00006454-199312003-00006"},{"key":"39826_CR10","doi-asserted-by":"crossref","unstructured":"Elstner, C. L., Lindsay, A. N., Book, L. S. & Matsen, J. M. Lack of relationship of Clostridium difficile to antibiotic-associated diarrhea in children. Pediatr Infect. Dis 2, 364\u2013366 .","DOI":"10.1097\/00006454-198309000-00006"},{"key":"39826_CR11","doi-asserted-by":"crossref","unstructured":"McFarland, L. V. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 16, 292\u2013307 .","DOI":"10.1159\/000016879"},{"key":"39826_CR12","doi-asserted-by":"crossref","unstructured":"Beaugerie, L. et al. Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol. Ther 17, 905\u2013912 .","DOI":"10.1046\/j.1365-2036.2003.01531.x"},{"key":"39826_CR13","doi-asserted-by":"crossref","unstructured":"Young, V. B. & Schmidt, T. M. Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin. Microbiol 42, 1203\u20131206 .","DOI":"10.1128\/JCM.42.3.1203-1206.2004"},{"key":"39826_CR14","doi-asserted-by":"crossref","unstructured":"Finkelstein, J. A. et al. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics 108, 1\u20137 .","DOI":"10.1542\/peds.108.1.1"},{"key":"39826_CR15","doi-asserted-by":"crossref","unstructured":"Finkelstein, J. A. et al. Antimicrobial use in defined populations of infants and young children. Arch Pediatr. Adolesc. Med 154, 395\u2013400 .","DOI":"10.1001\/archpedi.154.4.395"},{"key":"39826_CR16","doi-asserted-by":"crossref","unstructured":"Clausen, M. R., Bonn\u00e9n, H., Tvede, M. & Mortensen, P. B. Colonic fermentation to short-chain fatty acids is decreased in antibiotic-associated diarrhea. Gastroenterology 101, 1497\u20131504 .","DOI":"10.1016\/0016-5085(91)90384-W"},{"key":"39826_CR17","doi-asserted-by":"crossref","unstructured":"Merenstein, D. et al. Bifidobacterium animalis subsp. Lactis BB-12 protects against antibiotic-induced functional and compositional changes in human fecal Microbiome. Nutrients 13, 2814 .","DOI":"10.3390\/nu13082814"},{"key":"39826_CR18","doi-asserted-by":"crossref","unstructured":"Tan, T. P. et al. Safety of Bifidobacterium animalis subsp. Lactis (B. Lactis) strain BB-12-supplemented yogurt in healthy children. J Pediatr. Gastroenterol. Nutr 64, 302\u2013309 .","DOI":"10.1097\/MPG.0000000000001272"},{"key":"39826_CR19","doi-asserted-by":"crossref","unstructured":"Fuller, R. Probiotics in human medicine. Gut 32, 439\u2013442 .","DOI":"10.1136\/gut.32.4.439"},{"key":"39826_CR20","doi-asserted-by":"crossref","unstructured":"Perdigon, G., de Macias, M. E., Alvarez, S., Oliver, G. & de Ruiz Holgado A.A. Effect of perorally administered lactobacilli on macrophage activation in mice. Infect Immun 53, 404\u2013410 .","DOI":"10.1128\/iai.53.2.404-410.1986"},{"key":"39826_CR21","doi-asserted-by":"crossref","unstructured":"Wilson, K. H. & Perini, F. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun 56, 2610\u20132614 .","DOI":"10.1128\/iai.56.10.2610-2614.1988"},{"key":"39826_CR22","doi-asserted-by":"crossref","unstructured":"Pongpech, P., Hentges, D. J., Marsh, W. W. & Eberle, M. E. Effect of streptomycin administration on association of enteric pathogens with cecal tissue of mice. Infect Immun 57, 2092\u20132097 .","DOI":"10.1128\/iai.57.7.2092-2097.1989"},{"key":"39826_CR23","unstructured":"Sartor, R. B. Probiotic therapy of intestinal inflammation and infections. Curr Opin. Gastroenterol 21, 44\u201350 ."},{"key":"39826_CR24","doi-asserted-by":"crossref","unstructured":"Davidson, J. N. & Hirsh, D. C. Bacterial competition as a means of preventing neonatal diarrhea in pigs. Infect Immun 13, 1773\u20131774 .","DOI":"10.1128\/iai.13.6.1773-1774.1976"},{"key":"39826_CR25","doi-asserted-by":"crossref","unstructured":"Jungersen, M. et al. The science behind the probiotic strain Bifidobacterium animalis subsp. lactis BB-12\u00ae. Microorganisms 2, 92\u2013110 .","DOI":"10.3390\/microorganisms2020092"},{"key":"39826_CR26","unstructured":"Johnston, B. C., Goldenberg, J. Z., Vandvik, P. O. & Sun, X. Guyatt G.H. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst. Rev 11, CD004827 ."},{"key":"39826_CR27","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. Definition & facts for diarrhea. NIDDK. Accessed January 13. (2025). https:\/\/www.niddk.nih.gov\/health-information\/digestive-diseases\/diarrhea\/definition-facts"},{"key":"39826_CR28","doi-asserted-by":"crossref","unstructured":"Lewis, S. J. & Heaton, K. W. Stool form scale as a useful guide to intestinal transit time. Scand J. Gastroenterol 32, 920\u2013924 .","DOI":"10.3109\/00365529709011203"},{"key":"39826_CR29","doi-asserted-by":"crossref","unstructured":"Holm, J. B. et al. Ultrahigh-throughput multiplexing and sequencing of >\u2009500-base-pair amplicon regions on the Illumina HiSeq 2500 platform. mSystems. 4, e00029-19.","DOI":"10.1128\/msystems.00029-19"},{"key":"39826_CR30","doi-asserted-by":"crossref","unstructured":"Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ. Microbiol 73, 5261\u20135267 .","DOI":"10.1128\/AEM.00062-07"},{"key":"39826_CR31","doi-asserted-by":"crossref","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 41, D590\u2013596 .","DOI":"10.1093\/nar\/gks1219"},{"key":"39826_CR32","doi-asserted-by":"crossref","unstructured":"Callahan, B. J. et al. DADA2: high-resolution sample inference from illumina amplicon data. Nat Methods 13, 581\u2013583 .","DOI":"10.1038\/nmeth.3869"},{"key":"39826_CR33","doi-asserted-by":"crossref","unstructured":"Prochazkova, P. et al. The intestinal microbiota and metabolites in patients with anorexia nervosa. Gut Microbes 13, 1\u201325 .","DOI":"10.1080\/19490976.2021.1902771"},{"key":"39826_CR34","unstructured":"BBMap, S. F. January 15, Accessed January 19, 2025. (2025). https:\/\/sourceforge.net\/projects\/bbmap\/"},{"key":"39826_CR35","unstructured":"Introducing, R. H. human contaminant removal. SEQanswers. April 17, Accessed January 19, 2025. (2014). https:\/\/www.seqanswers.com\/forum\/bioinformatics\/bioinformatics-aa\/37175-introducing-removehuman-human-contaminant-removal"},{"key":"39826_CR36","doi-asserted-by":"crossref","unstructured":"Kaminski, J. et al. High-specificity targeted functional profiling in microbial communities with shortbred. PLoS Comput. Biol 11, e1004557 .","DOI":"10.1371\/journal.pcbi.1004557"},{"key":"39826_CR37","doi-asserted-by":"crossref","unstructured":"Alcock, B. P. et al. CARD 2023: expanded curation, support for machine learning, and resistome prediction at the comprehensive antibiotic resistance database. Nucleic Acids Res 51, D690\u2013D699 .","DOI":"10.1093\/nar\/gkac920"},{"key":"39826_CR38","doi-asserted-by":"crossref","unstructured":"Fox, J. & Weisberg, S. An R Companion To Applied Regression (Sage, 2018).","DOI":"10.32614\/CRAN.package.carData"},{"key":"39826_CR39","unstructured":"R Core Team. R: a language and environment for statistical computing; (2013)."},{"key":"39826_CR40","doi-asserted-by":"crossref","unstructured":"McMurdie, P. J. & Holmes, S. Phyloseq: an R package for reproducible interactive analysis and graphics of Microbiome census data. PLoS One 8, e61217 .","DOI":"10.1371\/journal.pone.0061217"},{"key":"39826_CR41","doi-asserted-by":"crossref","unstructured":"Cao, Y. et al. microbiomeMarker: an R\/Bioconductor package for microbiome marker identification and visualization. In: Marschall T, editor. Bioinformatics. 38, 4027\u20134029.","DOI":"10.1093\/bioinformatics\/btac438"},{"key":"39826_CR42","doi-asserted-by":"crossref","unstructured":"Villanueva, R. A. M. & Chen, Z. J. ggplot2: elegant graphics for data analysis (2nd ed.). Measurement: Interdisciplinary Res. Perspectives 17, 160\u2013167 .","DOI":"10.1080\/15366367.2019.1565254"},{"key":"39826_CR43","doi-asserted-by":"crossref","unstructured":"Gu, Z. Complex heatmap visualization. iMeta 1, e43.","DOI":"10.1002\/imt2.43"},{"key":"39826_CR44","unstructured":"Penicillins (1st Generation). In: LiverTox: clinical and research information on drug-induced liver injury & National Institute of Diabetes and Digestive and Kidney Diseases. Accessed January 13, 2025. (2012). http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548801\/"},{"key":"39826_CR45","unstructured":"Office of Dietary Supplements. Probiotics\u2014health professional fact sheet. National Institutes of Health. Updated March 2, 2023. Accessed April 30. (2025). https:\/\/ods.od.nih.gov\/factsheets\/Probiotics-HealthProfessional\/"},{"key":"39826_CR46","doi-asserted-by":"crossref","unstructured":"Zhang, J., Chen, L., Gomez-Simmonds, A., Yin, M. T. & Freedberg, D. E. Antibiotic-Specific risk for Community-Acquired clostridioides difficile infection in the united States from 2008 to 2020. Antimicrob Agents Chemother 66, 1129 .","DOI":"10.1128\/aac.01129-22"},{"key":"39826_CR47","doi-asserted-by":"crossref","unstructured":"Bartlett, J. G. Clinical practice. Antibiotic-associated diarrhea. N Engl. J. Med 346, 334\u2013339 .","DOI":"10.1056\/NEJMcp011603"},{"key":"39826_CR48","doi-asserted-by":"crossref","unstructured":"Huttner, A. et al. Oral amoxicillin and amoxicillin-clavulanic acid: properties, indications and usage. Clin Microbiol. Infect 26, 871\u2013879 .","DOI":"10.1016\/j.cmi.2019.11.028"},{"key":"39826_CR49","doi-asserted-by":"crossref","unstructured":"Lekang, K., Shekhar, S., Berild, D., Petersen, F. C. & Winther-Larsen, H. C. Effects of different amoxicillin treatment durations on Microbiome diversity and composition in the gut. PLoS One 17, e0275737 .","DOI":"10.1371\/journal.pone.0275737"},{"key":"39826_CR50","doi-asserted-by":"crossref","unstructured":"Lee, R. A. et al. Appropriate use of short-course antibiotics in common infections: best practice advice from the American college of physicians. Ann Intern. Med 174, 822\u2013827 .","DOI":"10.7326\/M20-7355"},{"key":"39826_CR51","doi-asserted-by":"crossref","unstructured":"Elvers, K. T. et al. Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review. BMJ Open 10, e035677 .","DOI":"10.1136\/bmjopen-2019-035677"},{"key":"39826_CR52","doi-asserted-by":"crossref","unstructured":"Spatz, M. et al. Antibiotic treatment using amoxicillin-clavulanic acid impairs gut mycobiota development through modification of the bacterial ecosystem. Microbiome 11, 73 .","DOI":"10.1186\/s40168-023-01516-y"},{"key":"39826_CR53","doi-asserted-by":"crossref","unstructured":"Martin, A. J. M., Serebrinsky-Duek, K., Riquelme, E., Saa, P. A. & Garrido, D. Microbial interactions and the homeostasis of the gut microbiome: the role of bifidobacterium. Microbiome Res. Rep 2, 17 .","DOI":"10.20517\/mrr.2023.10"},{"key":"39826_CR54","doi-asserted-by":"crossref","unstructured":"Montassier, E. et al. Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner. Nat Microbiol 6, 1043\u20131054 .","DOI":"10.1038\/s41564-021-00920-0"},{"key":"39826_CR55","doi-asserted-by":"crossref","unstructured":"Suez, J. et al. Post-antibiotic gut mucosal Microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell 174, 1406\u20131423e16 .","DOI":"10.1016\/j.cell.2018.08.047"},{"key":"39826_CR56","doi-asserted-by":"crossref","unstructured":"Suez, J., Zmora, N., Segal, E. & Elinav, E. The pros, cons, and many unknowns of probiotics. Nat Med 25, 716\u2013729 .","DOI":"10.1038\/s41591-019-0439-x"},{"key":"39826_CR57","unstructured":"Office of Dietary Supplements. Probiotics. Accessed January 13. (2025). https:\/\/ods.od.nih.gov\/factsheets\/Probiotics-HealthProfessional\/"},{"key":"39826_CR58","doi-asserted-by":"crossref","unstructured":"Hempel, S. et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307, 1959\u20131969 .","DOI":"10.1001\/jama.2012.3507"},{"key":"39826_CR59","unstructured":"Chatterjee, S. et al. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea. J Assoc. Physicians India 61, 708\u2013712 ."},{"key":"39826_CR60","doi-asserted-by":"crossref","unstructured":"Corr\u00eaa, N. B., P\u00e9ret Filho, L. A., Penna, F. J., Lima, F. M. & Nicoli, J. R. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. J Clin. Gastroenterol 39, 385\u2013389 .","DOI":"10.1097\/01.mcg.0000159217.47419.5b"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39826-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39826-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39826-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:38:36Z","timestamp":1773826716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39826-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39826"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39826-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of Georgetown University (protocol 2016\u2009\u2212\u20091489). This study is registered at ClinicalTrials.gov (NCT#03181516).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"was obtained from all subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"9301"}}